1 Fouchier, R. A. et al. Characterization of a novel influenza A virus hemagglutinin subtype (H16) obtained from black-headed gulls. J Virol 79, 2814-2822, doi:10.1128/JVI.79.5.2814- 2822.2005 (2005).
2 Webster, R. G., Bean, W. J., Gorman, O. T., Chambers, T. M. & Kawaoka, Y. Evolution and Ecology of Influenza-a Viruses. Microbiol Rev 56, 152-179 (1992).
3 Tong, S. et al. A distinct lineage of influenza A virus from bats. Proc Natl Acad Sci U S A 109, 4269-4274, doi:10.1073/pnas.1116200109 (2012).
4 Tong, S. et al. New world bats harbor diverse influenza A viruses. PLoS Pathog 9, e1003657, doi:10.1371/journal.ppat.1003657 (2013).
5 Osterhaus, A. D., Rimmelzwaan, G. F., Martina, B. E., Bestebroer, T. M. & Fouchier, R. A. Influenza B virus in seals. Science 288, 1051-1053, doi:10.1126/science.288.5468.1051 (2000).
6 Rota, P. A. et al. Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983. Virology 175, 59-68, doi:10.1016/0042-6822(90)90186-u (1990).
7 Skehel, J. J. & Wiley, D. C. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu Rev Biochem 69, 531-569, doi:10.1146/annurev.biochem.69.1.531 (2000).
8 Hay, A. J., Gregory, V., Douglas, A. R. & Lin, Y. P. The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci 356, 1861-1870, doi:10.1098/rstb.2001.0999 (2001).
9 Carrat, F. & Flahault, A. Influenza vaccine: the challenge of antigenic drift. Vaccine 25, 6852- 6862, doi:10.1016/j.vaccine.2007.07.027 (2007).
10 Palese, P., Tobita, K., Ueda, M. & Compans, R. W. Characterization of Temperature Sensitive Influenza-Virus Mutants Defective in Neuraminidase. Virology 61, 397-410, doi:Doi 10.1016/0042-6822(74)90276-1 (1974).
11 Liu, C. G., Eichelberger, M. C., Compans, R. W. & Air, G. M. Influenza Type-a Virus Neuraminidase Does Not Play a Role in Viral Entry, Replication, Assembly, or Budding. Journal of Virology 69, 1099-1106 (1995).
12 Gubareva, L. V., Robinson, M. J., Bethell, R. C. & Webster, R. G. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidinoNeu5Ac2en. J Virol 71, 3385-3390 (1997).
13 Oakley, A. J. et al. Structural and functional basis of resistance to neuraminidase inhibitors of influenza B viruses. J Med Chem 53, 6421-6431, doi:10.1021/jm100621s (2010).
14 Collins, P. J. et al. Crystal structures of oseltamivir-resistant influenza virus neuraminidase mutants. Nature 453, 1258-1261, doi:10.1038/nature06956 (2008).
15 Chambers, B. S., Li, Y., Hodinka, R. L. & Hensley, S. E. Recent H3N2 influenza virus clinical isolates rapidly acquire hemagglutinin or neuraminidase mutations when propagated for antigenic analyses. J Virol 88, 10986-10989, doi:10.1128/JVI.01077-14 (2014).
16 Mishin, V. P. et al. The effect of the MDCK cell selected neuraminidase D151G mutation on the drug susceptibility assessment of influenza A(H3N2) viruses. Antiviral Res 101, 93-96, doi:10.1016/j.antiviral.2013.11.001 (2014).
17 McKimm-Breschkin, J. et al. Neuraminidase Sequence Analysis and Susceptibilities of Influenza Virus Clinical Isolates to Zanamivir and Oseltamivir. Antimicrobial Agents and Chemotherapy 47, 2264-2272, doi:10.1128/aac.47.7.2264-2272.2003 (2003).
18 Lee, H. K. et al. Comparison of mutation patterns in full-genome A/H3N2 influenza sequences obtained directly from clinical samples and the same samples after a single MDCK passage. PLoS One 8, e79252, doi:10.1371/journal.pone.0079252 (2013).
19 Tamura, D. et al. Cell culture-selected substitutions in influenza A(H3N2) neuraminidase affect drug susceptibility assessment. Antimicrob Agents Chemother 57, 6141-6146, doi:10.1128/AAC.01364-13 (2013).
20 Lin, Y. et al. The characteristics and antigenic properties of recently emerged subclade 3C.3a and 3C.2a human influenza A(H3N2) viruses passaged in MDCK cells. Influenza Other Respir Viruses 11, 263-274, doi:10.1111/irv.12447 (2017).
21 Li, D. et al. In vivo and in vitro alterations in influenza A/H3N2 virus M2 and hemagglutinin genes: effect of passage in MDCK-SIAT1 cells and conventional MDCK cells. J Clin Microbiol 47, 466-468, doi:10.1128/JCM.00892-08 (2009).
22 Oh, D. Y., Barr, I. G., Mosse, J. A. & Laurie, K. L. MDCK-SIAT1 cells show improved isolation rates for recent human influenza viruses compared to conventional MDCK cells. J Clin Microbiol 46, 2189-2194, doi:10.1128/JCM.00398-08 (2008).
23 Mohr, P. G., Deng, Y. M. & McKimm-Breschkin, J. L. The neuraminidases of MDCK grown human influenza A(H3N2) viruses isolated since 1994 can demonstrate receptor binding. Virol J 12, 67, doi:10.1186/s12985-015-0295-3 (2015).
24 Lin, Y. P. et al. Neuraminidase receptor binding variants of human influenza A(H3N2) viruses resulting from substitution of aspartic acid 151 in the catalytic site: a role in virus attachment? J Virol 84, 6769-6781, doi:10.1128/JVI.00458-10 (2010).
25 Zhu, X. et al. Influenza virus neuraminidases with reduced enzymatic activity that avidly bind sialic Acid receptors. J Virol 86, 13371-13383, doi:10.1128/JVI.01426-12 (2012).
26 Connor, R. J., Kawaoka, Y., Webster, R. G. & Paulson, J. C. Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology 205, 17-23, doi:10.1006/viro.1994.1615 (1994).
27 Rogers, G. N. & Paulson, J. C. Receptor determinants of human and animal influenza virus isolates: differences in receptor specificity of the H3 hemagglutinin based on species of origin. Virology 127, 361-373 (1983).
28 Stevens, J. et al. Glycan microarray analysis of the hemagglutinins from modern and pandemic influenza viruses reveals different receptor specificities. J Mol Biol 355, 1143-1155, doi:10.1016/j.jmb.2005.11.002 (2006).
29 van Riel, D. et al. H5N1 Virus Attachment to Lower Respiratory Tract. Science 312, 399, doi:10.1126/science.1125548 (2006).
30 Shinya, K. et al. Avian flu: influenza virus receptors in the human airway. Nature 440, 435-436, doi:10.1038/440435a (2006).
31 Ito, T. et al. Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol 72, 7367-7373 (1998).
32 Lin, S. C., Kappes, M. A., Chen, M. C., Lin, C. C. & Wang, T. T. Distinct susceptibility and applicability of MDCK derivatives for influenza virus research. PLoS One 12, e0172299, doi:10.1371/journal.pone.0172299 (2017).
33 Hatakeyama, S. et al. Enhanced expression of an alpha2,6-linked sialic acid on MDCK cells improves isolation of human influenza viruses and evaluation of their sensitivity to a neuraminidase inhibitor. J Clin Microbiol 43, 4139-4146, doi:10.1128/JCM.43.8.4139- 4146.2005 (2005).
34 Matrosovich, M., Matrosovich, T., Carr, J., Roberts, N. A. & Klenk, H. D. Overexpression of the -2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors. Journal of Virology 77, 8418-8425, doi:10.1128/jvi.77.15.8418- 8425.2003 (2003).
35 Hidari, K. I. et al. Influenza virus utilizes N-linked sialoglycans as receptors in A549 cells. Biochem Biophys Res Commun 436, 394-399, doi:10.1016/j.bbrc.2013.05.112 (2013).
36 Isakov, O. et al. Deep sequencing analysis of viral infection and evolution allows rapid and detailed characterization of viral mutant spectrum. Bioinformatics 31, 2141-2150, doi:10.1093/bioinformatics/btv101 (2015).
37 Martin, J. A. & Wang, Z. Next-generation transcriptome assembly. Nature Reviews Genetics 12, 671-682, doi:10.1038/nrg3068 (2011).
38 Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15-21, doi:10.1093/bioinformatics/bts635 (2013).
39 Grabherr, M. G. et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29, 644-652, doi:10.1038/nbt.1883 (2011).
40 Kent, W. J. BLAT--the BLAST-like alignment tool. Genome Res 12, 656-664, doi:10.1101/gr.229202 (2002).
41 Li, W. Z., Jaroszewski, L. & Godzik, A. Clustering of highly homologous sequences to reduce the size of large protein databases. Bioinformatics 17, 282-283, doi:DOI 10.1093/bioinformatics/17.3.282 (2001).
42 Li, W. & Godzik, A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658-1659, doi:10.1093/bioinformatics/btl158 (2006).
43 Li, H. & Durbin, R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25, 1754-1760, doi:10.1093/bioinformatics/btp324 (2009).
44 Lenth, R. V. Least-Squares Means: TheRPackagelsmeans. J Stat Softw 69, doi:10.18637/jss.v069.i01 (2016).
45 Bates, D., Machler, M., Bolker, B. M. & Walker, S. C. Fitting Linear Mixed-Effects Models Using lme4. J Stat Softw 67, 1-48 (2015).
46 Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819- 823, doi:10.1126/science.1231143 (2013).
47 Jinek, M. et al. A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science 337, 816-821, doi:10.1126/science.1225829 (2012).
48 Han, J. et al. Genome-wide CRISPR/Cas9 Screen Identifies Host Factors Essential for Influenza Virus Replication. Cell Rep 23, 596-607, doi:10.1016/j.celrep.2018.03.045 (2018).
49 Shalem, O. et al. Genome-scale CRISPR-Cas9 knockout screening in human cells. Science 343, 84-87, doi:10.1126/science.1247005 (2014).
50 Takashima, S. & Tsuji, S. Functional Diversity of Mammalian Sialyltransferases. Trends in Glycoscience and Glycotechnology 23, 178-193, doi:10.4052/tigg.23.178 (2011).
51 Chu, V. C. & Whittaker, G. R. Influenza virus entry and infection require host cell N-linked glycoprotein. Proc Natl Acad Sci U S A 101, 18153-18158, doi:10.1073/pnas.0405172102 (2004).
52 Shibuya, N. et al. A comparative study of bark lectins from three elderberry (Sambucus) species. J Biochem 106, 1098-1103 (1989).
53 Chambers, B. S., Parkhouse, K., Ross, T. M., Alby, K. & Hensley, S. E. Identification of Hemagglutinin Residues Responsible for H3N2 Antigenic Drift during the 2014-2015 Influenza Season. Cell Rep 12, 1-6, doi:10.1016/j.celrep.2015.06.005 (2015).
54 Skowronski, D. M. et al. Mutations acquired during cell culture isolation may affect antigenic characterisation of influenza A(H3N2) clade 3C.2a viruses. Euro Surveill 21, 30112, doi:10.2807/1560-7917.ES.2016.21.3.30112 (2016).
55 Saito, T. et al. Antigenic alteration of influenza B virus associated with loss of a glycosylation site due to host-cell adaptation. J Med Virol 74, 336-343, doi:10.1002/jmv.20178 (2004).
56 Lin, Y. P. et al. Evolution of the receptor binding properties of the influenza A(H3N2) hemagglutinin (vol 109, pg 21474, 2012). P Natl Acad Sci USA 110, 2677-2677, doi:10.1073/pnas.1222337110 (2013).
57 Harduin-Lepers, A. et al. The human sialyltransferase family. Biochimie 83, 727-737 (2001).
58 Peng, W. et al. Recent H3N2 Viruses Have Evolved Specificity for Extended, Branched Humantype Receptors, Conferring Potential for Increased Avidity. Cell Host Microbe 21, 23-34, doi:10.1016/j.chom.2016.11.004 (2017).
59 Tatsuo, H., Ono, N., Tanaka, K. & Yanagi, Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 406, 893, doi:10.1038/35022579 (2000).
60 Li, L. & Qi, Y. A novel amino acid position in hemagglutinin glycoprotein of measles virus is responsible for hemadsorption and CD46 binding. Arch Virol 147, 775-786 (2002).
61 Nielsen, L., Blixenkrone-Moller, M., Thylstrup, M., Hansen, N. J. & Bolt, G. Adaptation of wild-type measles virus to CD46 receptor usage. Arch Virol 146, 197-208 (2001).